Tearsheet
AVD Home Investment Highlights Valuation, Metrics & Events Price Chart Why The Stock Moved Return vs. Risk About AVD Interactive Breakdown Better Bets vs. AVD Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Trade Sentinel Industry Resource Links External Quote Links

American Vanguard (AVD)

Market Price (5/26/2026): $2.8 | Market Cap: $80.2 Mil
Sector: Materials | Industry: Fertilizers & Agricultural Chemicals

American Vanguard (AVD)

Market Price (5/26/2026): $2.8
Market Cap: $80.2 Mil
Sector: Materials
Industry: Fertilizers & Agricultural Chemicals

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -27%

Megatrend and thematic drivers
Megatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more.

Weak multi-year price returns
2Y Excs Rtn is -110%, 3Y Excs Rtn is -163%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 264%

Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5%

Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -6.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.8%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -61%

Key risks
AVD key risks include [1] significant financial instability and operational control deficiencies, Show more.

0 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -27%
1 Megatrend and thematic drivers
Megatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more.
2 Weak multi-year price returns
2Y Excs Rtn is -110%, 3Y Excs Rtn is -163%
3 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 264%
4 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.5%
5 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -6.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.8%
6 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -61%
7 Key risks
AVD key risks include [1] significant financial instability and operational control deficiencies, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

American Vanguard (AVD) stock has lost about 45% since 1/31/2026 because of the following key factors:

1. American Vanguard reported a significant miss in its Q4 2025 earnings, coupled with weak full-year financial results. The company posted an earnings per share (EPS) of -$0.99 for Q4 2025, missing analysts' expectations of $0.28 by 453.57%. For the full year 2025, net sales declined by 6% to $515 million, falling short of the targeted range of $520 million to $535 million. Adjusted EBITDA for 2025, at $39.2 million, remained nearly flat year-over-year but was below the company's target of $40 million to $44 million, primarily due to sluggish sales in the fourth quarter.

2. Persistent challenging macroeconomic conditions in the agricultural sector impacted demand for the company's products. The agricultural market experienced headwinds throughout 2025, characterized by elevated channel inventories and adverse weather conditions in key international markets, which collectively suppressed demand. This broader industry downturn contributed to American Vanguard's underperformance and a cautious outlook on future revenue growth.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -44.7% change in AVD stock from 1/31/2026 to 5/25/2026 was primarily driven by a -43.7% change in the company's P/S Multiple.
(LTM values as of)13120265252026Change
Stock Price ($)5.082.81-44.7%
Change Contribution By: 
Total Revenues ($ Mil)530523-1.4%
P/S Multiple0.30.2-43.7%
Shares Outstanding (Mil)2929-0.5%
Cumulative Contribution-44.7%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/25/2026
ReturnCorrelation
AVD-44.7% 
Market (SPY)8.1%26.2%
Sector (XLB)2.5%32.8%

Fundamental Drivers

The -37.1% change in AVD stock from 10/31/2025 to 5/25/2026 was primarily driven by a -35.7% change in the company's P/S Multiple.
(LTM values as of)103120255252026Change
Stock Price ($)4.472.81-37.1%
Change Contribution By: 
Total Revenues ($ Mil)529523-1.2%
P/S Multiple0.20.2-35.7%
Shares Outstanding (Mil)2829-1.1%
Cumulative Contribution-37.1%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/25/2026
ReturnCorrelation
AVD-37.1% 
Market (SPY)9.9%23.8%
Sector (XLB)18.5%34.3%

Fundamental Drivers

The -33.4% change in AVD stock from 4/30/2025 to 5/25/2026 was primarily driven by a -28.3% change in the company's P/S Multiple.
(LTM values as of)43020255252026Change
Stock Price ($)4.222.81-33.4%
Change Contribution By: 
Total Revenues ($ Mil)554523-5.6%
P/S Multiple0.20.2-28.3%
Shares Outstanding (Mil)2829-1.7%
Cumulative Contribution-33.4%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/25/2026
ReturnCorrelation
AVD-33.4% 
Market (SPY)36.0%21.1%
Sector (XLB)22.2%34.0%

Fundamental Drivers

The -85.2% change in AVD stock from 4/30/2023 to 5/25/2026 was primarily driven by a -82.6% change in the company's P/S Multiple.
(LTM values as of)43020235252026Change
Stock Price ($)19.012.81-85.2%
Change Contribution By: 
Total Revenues ($ Mil)610523-14.2%
P/S Multiple0.90.2-82.6%
Shares Outstanding (Mil)2829-0.7%
Cumulative Contribution-85.2%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2023 to 5/25/2026
ReturnCorrelation
AVD-85.2% 
Market (SPY)86.3%21.0%
Sector (XLB)32.4%32.1%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
AVD Return6%33%-49%-58%-17%-25%-81%
Peers Return48%15%-21%-7%-3%16%41%
S&P 500 Return27%-19%24%23%16%9%98%

Monthly Win Rates [3]
AVD Win Rate42%42%50%25%42%40% 
Peers Win Rate65%58%42%48%50%56% 
S&P 500 Win Rate75%42%67%75%67%60% 

Max Drawdowns [4]
AVD Max Drawdown-36%-29%-63%-67%-46%-62% 
Peers Max Drawdown-20%-31%-41%-24%-36%-21% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 

[1] Cumulative total returns since the beginning of 2021
[2] Peers: CTVA, FMC, NTR, MOS, CF.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/22/2026 (YTD)

How Low Can It Go

EventAVDS&P 500
2025 US Tariff Shock
  % Loss-37.0%-18.8%
  % Gain to Breakeven58.8%23.1%
  Time to Breakeven150 days79 days
2022 Inflation Shock & Fed Tightening
  % Loss-12.6%-24.5%
  % Gain to Breakeven14.4%32.4%
  Time to Breakeven12 days427 days
2020 COVID-19 Crash
  % Loss-34.4%-33.7%
  % Gain to Breakeven52.5%50.9%
  Time to Breakeven297 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-26.0%-19.2%
  % Gain to Breakeven35.1%23.8%
  Time to Breakeven78 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-11.0%-12.2%
  % Gain to Breakeven12.3%13.9%
  Time to Breakeven17 days62 days
2014-2016 Oil Price Collapse
  % Loss-28.7%-6.8%
  % Gain to Breakeven40.2%7.3%
  Time to Breakeven205 days15 days

Compare to CTVA, FMC, NTR, MOS, CF

In The Past

American Vanguard's stock fell -37.0% during the 2025 US Tariff Shock. Such a loss loss requires a 58.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventAVDS&P 500
2025 US Tariff Shock
  % Loss-37.0%-18.8%
  % Gain to Breakeven58.8%23.1%
  Time to Breakeven150 days79 days
2020 COVID-19 Crash
  % Loss-34.4%-33.7%
  % Gain to Breakeven52.5%50.9%
  Time to Breakeven297 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-26.0%-19.2%
  % Gain to Breakeven35.1%23.8%
  Time to Breakeven78 days105 days
2014-2016 Oil Price Collapse
  % Loss-28.7%-6.8%
  % Gain to Breakeven40.2%7.3%
  Time to Breakeven205 days15 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-28.8%-17.9%
  % Gain to Breakeven40.4%21.8%
  Time to Breakeven141 days123 days
2008-2009 Global Financial Crisis
  % Loss-59.0%-53.4%
  % Gain to Breakeven144.1%114.4%
  Time to Breakeven1203 days1085 days
Summer 2007 Credit Crunch
  % Loss-29.0%-8.6%
  % Gain to Breakeven40.9%9.5%
  Time to Breakeven34 days47 days

Compare to CTVA, FMC, NTR, MOS, CF

In The Past

American Vanguard's stock fell -37.0% during the 2025 US Tariff Shock. Such a loss loss requires a 58.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About American Vanguard (AVD)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.

AI Analysis | Feedback

  • It's like a smaller, specialized BASF or DuPont, but entirely focused on chemicals for agriculture and plant health.

  • Think of it as the 'Johnson & Johnson' for the agricultural sector, providing a wide array of specialty chemicals for crop protection, soil health, and plant nutrition.

AI Analysis | Feedback

  • Insecticides: Chemicals designed to control insect pests.
  • Fungicides: Chemicals used to prevent and control fungal diseases in plants.
  • Herbicides: Chemicals specifically formulated for weed control.
  • Molluscicides: Products used to manage mollusc populations.
  • Soil Health & Plant Nutrition Products: Solutions aimed at improving soil vitality and delivering essential nutrients to plants.
  • Plant Growth Regulators: Chemicals that modify or regulate the growth processes of plants.
  • Soil Fumigants: Specialized chemicals used to sterilize soil by eliminating pests and pathogens.
  • End-Use Crop Protection Products: A range of chemical and biological products marketed for direct application in crop cultivation.
  • Chemical Distribution Services: The distribution of specialty chemicals primarily for turf and ornamental markets.

AI Analysis | Feedback

American Vanguard (AVD) primarily sells its specialty chemical products to other companies rather than directly to individual consumers. The company operates on a business-to-business (B2B) model, distributing its products through a network of partners.

Based on company disclosures, its major customers are not publicly named but fall into the following general categories:

  • National Distribution Companies: These are large-scale distributors specializing in agricultural, commercial, and turf & ornamental chemical products, which then supply a wide array of end-users including farmers, landscapers, and various commercial operations.
  • Buying Groups or Co-operatives: These organizations represent numerous agricultural producers or businesses, allowing them to collectively purchase products from suppliers like American Vanguard at potentially more favorable terms.
  • Wholly Owned Distributors: American Vanguard also uses its own distribution channels and subsidiaries to reach specific markets or customer segments.

While American Vanguard's financial filings (e.g., 10-K reports) indicate that a significant portion of its total net sales comes from a few major, unnamed customers, the specific names of these customer companies and their symbols are not publicly disclosed by the company due to confidentiality.

AI Analysis | Feedback

null

AI Analysis | Feedback

Douglas A. ("Dak") Kaye III Chief Executive Officer

Mr. Kaye was appointed CEO in December 2024. Prior to joining American Vanguard in 2024, he held various senior leadership roles at Albaugh LLC, a global crop protection company, including President, North America, and Group Chief Commercial Officer. He also served as President of Albaugh's European region for seven years. Before Albaugh, Mr. Kaye was the CFO and a Director at a non-crop subsidiary of the crop protection company Adama and previously held the role of Co-CEO at an international automotive logistics organization. He began his career at Arthur Andersen, LLP.

David T. Johnson Chief Financial Officer

Mr. Johnson has served as Vice President, CFO, and Treasurer of American Vanguard since March 2008. Prior to his tenure at American Vanguard, he was the Finance Director for Amcor Flexibles UK Ltd., a manufacturer of decorative packaging and a subsidiary of Amcor, from June 2003 through March 2008. Before that, he served as Vice President of Finance for Sterer Engineering, a subsidiary of Eaton Aerospace, from April 2001 through June 2003.

Timothy J. Donnelly Chief Information Officer, General Counsel & Secretary

Mr. Donnelly has served as Chief Information Officer, General Counsel, and Secretary of American Vanguard. He joined the company in October 2005 as Vice President, General Counsel and Assistant Secretary, was appointed Secretary in June 2007, and assumed responsibility for Human Resources and Risk Management in 2009. Prior to American Vanguard, from September 2000 through October 2005, Mr. Donnelly served as Vice President, General Counsel and Secretary for DDi Corp. (Nasdaq—DDIC), a manufacturer of printed circuit boards. He also held roles as Assistant General Counsel at Rockwell International Corporation and an Associate at the law firm Latham & Watkins.

Shirin Khosravi Chief Human Resources Officer

Ms. Khosravi joined American Vanguard as Senior Vice President of Human Resources in October 2023. She brings over 30 years of progressive international human resources experience from various Fortune 500 companies, including Dover Corporation, CRH, and Holcim.

Mike DiPaola Chief Commercial Officer

Mr. DiPaola was appointed Chief Commercial Officer in January 2026. He joined American Vanguard in February 2025 and previously served as Senior Vice President of Strategy, Marketing, & R&D, where he led strategic initiatives, product development, regulatory and government affairs, mergers and acquisitions, marketing strategies, and research and development. Prior to American Vanguard, Mr. DiPaola was Chief Commercial Officer and General Manager at Taranis, an AI-powered crop intelligence platform. Earlier in his career, he held senior leadership positions at Syngenta and Southern States Cooperative.

AI Analysis | Feedback

The public company American Vanguard (symbol: AVD) faces several key risks to its business.

Key Risks to American Vanguard (AVD)

  1. Regulatory Pressures and Product Portfolio Transformation

    American Vanguard faces significant risks from evolving regulatory policies that are phasing out older chemical products. The U.S. Environmental Protection Agency (EPA) has, for example, suspended registrations for dimethyl tetrachloroterephthalate (DCPA), also known as Dacthal, a key product for American Vanguard, due to reported health risks. This regulatory action necessitated a substantial charge for the collection and disposal of the product. This environment mandates a costly and strategic pivot of the company's product portfolio towards high-growth biologicals and digital agriculture technologies to maintain competitiveness, requiring significant investment while managing the decline of legacy products.

  2. Intense Competition and Market Pricing Pressures

    Operating within a fiercely competitive agrochemical sector dominated by much larger industry giants, American Vanguard faces a scale disadvantage and a significant research and development (R&D) investment gap. The global biologicals market is rapidly growing, creating both opportunities and disruptive forces as the industry shifts away from traditional synthetic pesticides. This shift, coupled with a brutal pricing environment and hyper-aggressive discounting by rivals, has led to substantial pressure on American Vanguard's gross margins and net sales.

  3. Supply Chain Vulnerabilities and Operational Execution Challenges

    American Vanguard is exposed to supply chain fragilities due to its reliance on a limited number of suppliers for critical raw materials, with some components available from single or very few sources globally. Disruptions in the global supply chain, including those from sourcing and manufacturing outside the U.S., tariffs, and international trade disputes, continue to pose risks of delays and raw material unavailability. Furthermore, the company has faced internal operational execution challenges, including reported material weaknesses in its internal controls over financial reporting, leading to delayed SEC filings and complications related to an Enterprise Resource Planning (ERP) system rollout. A recent ransomware attack also highlights cybersecurity as an ongoing operational risk.

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

American Vanguard Corporation operates in several addressable markets for its main agricultural chemical products.

Herbicides

  • The global herbicides market was valued at approximately USD 32.47 billion in 2025 and is projected to grow to USD 51.89 billion by 2034.
  • The U.S. herbicides market is estimated at USD 11.45 billion in 2025 and is expected to reach USD 14.37 billion by 2030.

Fungicides

  • The global fungicides market size was valued at USD 25.34 billion in 2025 and is projected to grow from USD 26.92 billion in 2026 to USD 43.73 billion by 2034.
  • The United States fungicide market size reached around USD 1.38 billion in 2025 and is projected to grow to nearly USD 1.85 billion by 2035.

Insecticides

  • The global insecticides market size was calculated at USD 21.38 billion in 2024 and is predicted to increase to approximately USD 36.43 billion by 2034.
  • The U.S. insecticides market size is estimated at USD 7.98 billion in 2025 and is expected to reach USD 9.85 billion by 2030.

Soil Fumigants

  • The global soil fumigant market size was valued at USD 2.32 billion in 2024 and is expected to reach USD 3.79 billion by 2033.
  • The U.S. agricultural fumigants market was valued at USD 375.0 million in 2024.
```

AI Analysis | Feedback

American Vanguard Corporation (AVD) is expected to drive future revenue growth over the next two to three years through several key initiatives and market recoveries:

  1. Recovery from Industry Destocking and Improved Agricultural Input Demand: The company anticipates a rebound from the global destocking within the distribution channel that has impacted sales, coupled with an expected improvement in overall agricultural input demand. This normalization of procurement patterns is projected to accelerate revenue growth in the coming years.

  2. Business and Digital Transformation Initiatives: American Vanguard is implementing comprehensive business and digital transformation efforts. These initiatives aim to optimize manufacturing, reduce raw material and selling expenses, enhance operating leverage, and create a more efficient platform for sustained growth and profitability.

  3. Expansion of Green Solutions Portfolio: AVD is strategically positioned for a sustainability-minded future through its "Green Solutions" portfolio. This segment includes over 120 biological solutions, such as specialty nutritionals, biopesticides, biostimulants, and biofertilizers, which are expected to contribute to revenue growth as demand for sustainable agricultural inputs increases.

  4. Advancement in Precision Agriculture Technologies: The company is a recognized leader in precision agriculture, particularly with its SIMPAS prescriptive application and Ultimus measure/record/verify technologies. These technologies enable targeted application of crop protection and bio-nutritional inputs, representing a key area for technological innovation and market expansion.

AI Analysis | Feedback

Share Repurchases

  • In May 2023, American Vanguard's Board of Directors authorized a program to repurchase up to $15 million of common stock over the subsequent twelve months, commencing in June 2023.
  • The company executed an accelerated share repurchase (ASR) plan of $20 million in August 2022, supplementing an existing 10b5-1 repurchase plan from March 2022.
  • In August 2021, the Board approved a program for repurchasing up to 300,000 shares of common stock over six months to help offset the expansion of outstanding shares from employee equity awards.
  • No common stock repurchases were made in 2024.

Share Issuance

  • The number of common shares issued increased from 34,794,548 at December 31, 2024, to 34,850,030 at March 31, 2025, and further to 34,970,687 at September 30, 2025.

Outbound Investments

  • In October 2023, American Vanguard acquired Punto Verde, an Ecuadorian company specializing in the distribution of crop protection products.
  • AVD Australia acquired 100% of AgNova, an Australian company focused on specialty crop protection and production solutions, in October 2020.
  • AMVAC, a subsidiary of American Vanguard, completed the purchase of all outstanding shares of Agrinos and certain intellectual property rights in October 2020.

Capital Expenditures

  • American Vanguard reported capital expenditures of -$7.28 million in fiscal year 2024, -$11.88 million in fiscal year 2023, -$13.26 million in fiscal year 2022, and -$9.52 million in fiscal year 2021.
  • The company anticipates capital expenditures of approximately $10 million for 2025, with an allocation focus on debt reduction.
  • Capital expenditure efforts are directed towards investments in manufacturing technology, new product development, Green Solutions, and precision agriculture technologies.

Better Bets vs. American Vanguard (AVD)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select ideas related to AVD.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CDE_4302026_Dip_Buyer_FCFYield04302026CDECoeur MiningDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.0%0.0%0.0%
AXTA_3272026_Dip_Buyer_FCFYield03272026AXTAAxalta Coating SystemsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.9%5.9%-2.7%
IFF_3272026_Insider_Buying_GTE_1Mil_EBITp+DE_V203272026IFFInternational Flavors & FragrancesInsiderInsider Buys | Low D/EStrong Insider Buying
Companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap		-1.1%-1.1%-3.0%
IP_3132026_Insider_Buying_GTE_1Mil_EBITp+DE_V203132026IPInternational PaperInsiderInsider Buys | Low D/EStrong Insider Buying
Companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap		-18.3%-18.3%-18.3%
ARIS_3062026_Dip_Buyer_FCFYield03062026ARISAris MiningDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-7.4%-7.4%-16.7%

Recent Active Movers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons

Peers to compare with:

Financials

AVDCTVAFMCNTRMOSCFMedian
NameAmerican.Corteva FMC Nutrien Mosaic CF Indus. 
Mkt Price2.8179.5613.1170.1322.51121.7046.32
Mkt Cap0.153.51.633.87.118.813.0
Rev LTM52317,8893,43527,83112,4307,4079,918
Op Inc LTM192,9592524,0826002,5881,594
FCF LTM-412,046-2202,208-4891,618789
FCF 3Y Avg-312,009611,9991461,326736
CFO LTM-362,624-1384,2388862,6621,755
CFO 3Y Avg-232,5801514,2051,4952,4431,969

Growth & Margins

AVDCTVAFMCNTRMOSCFMedian
NameAmerican.Corteva FMC Nutrien Mosaic CF Indus. 
Rev Chg LTM-1.0%6.3%-16.6%8.4%12.3%20.9%7.3%
Rev Chg 3Y Avg-3.5%0.4%-15.0%-7.7%-11.0%-6.5%-7.1%
Rev Chg Q6.7%11.0%-4.1%18.5%14.4%19.4%12.7%
QoQ Delta Rev Chg LTM1.5%2.8%-0.9%3.5%3.1%4.6%3.0%
Op Inc Chg LTM144.1%28.8%-63.3%48.8%-23.8%37.6%33.2%
Op Inc Chg 3Y Avg-39.8%13.1%-32.1%-11.4%-38.3%-5.8%-21.7%
Op Mgn LTM3.6%16.5%7.3%14.7%4.8%34.9%11.0%
Op Mgn 3Y Avg0.0%13.9%12.7%12.6%6.4%31.4%12.6%
QoQ Delta Op Mgn LTM1.3%1.4%-2.2%0.3%-4.1%1.4%0.8%
CFO/Rev LTM-6.9%14.7%-4.0%15.2%7.1%35.9%10.9%
CFO/Rev 3Y Avg-4.1%15.0%3.5%15.3%12.3%37.4%13.7%
FCF/Rev LTM-7.8%11.4%-6.4%7.9%-3.9%21.8%2.0%
FCF/Rev 3Y Avg-5.4%11.7%1.2%7.2%1.2%20.1%4.2%

Valuation

AVDCTVAFMCNTRMOSCFMedian
NameAmerican.Corteva FMC Nutrien Mosaic CF Indus. 
Mkt Cap0.153.51.633.87.118.813.0
P/S0.23.00.51.20.62.50.9
P/Op Inc4.318.16.58.311.97.37.8
P/EBIT-3.227.6-0.98.68.26.77.5
P/E-1.846.0-0.714.1158.810.712.4
P/CFO-2.220.4-11.98.08.17.07.5
Total Yield-56.6%2.6%-147.5%10.2%4.6%11.1%3.6%
Dividend Yield0.0%0.4%5.0%3.1%3.9%1.7%2.4%
FCF Yield 3Y Avg-21.2%4.4%-1.3%6.8%1.1%8.5%2.7%
D/E3.50.12.80.40.80.20.6
Net D/E2.60.02.50.40.80.10.6

Returns

AVDCTVAFMCNTRMOSCFMedian
NameAmerican.Corteva FMC Nutrien Mosaic CF Indus. 
1M Rtn-5.1%-0.3%-11.9%-2.0%-5.3%1.0%-3.5%
3M Rtn-43.9%4.3%-3.6%-1.8%-20.2%28.0%-2.7%
6M Rtn-35.3%21.8%0.5%26.7%-1.9%58.2%11.1%
12M Rtn-32.1%16.3%-64.2%21.7%-33.2%39.8%-7.9%
3Y Rtn-83.5%49.1%-85.7%42.4%-26.9%107.4%7.8%
1M Excs Rtn-4.1%-5.2%-14.4%-8.0%-11.5%-7.8%-7.9%
3M Excs Rtn-53.2%-5.0%-12.9%-11.1%-29.5%18.7%-12.0%
6M Excs Rtn-48.8%11.1%-8.1%14.9%-18.1%43.5%1.5%
12M Excs Rtn-61.8%-11.4%-93.0%-6.2%-61.9%11.3%-36.6%
3Y Excs Rtn-162.9%-32.7%-166.0%-49.4%-109.4%23.6%-79.4%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Developing, manufacturing and distributing chemical, biological and biorational products for547579   
Single Segment  610558459
Total547579610558459


Operating Income by Segment
$ Mil20252024202320222021
Developing, manufacturing and distributing chemical, biological and biorational products for-102    
Total-102    


Net Income by Segment
$ Mil20252024202320222021
Developing, manufacturing and distributing chemical, biological and biorational products for-1268   
Total-1268   


Price Behavior

Price Behavior
Market Price$2.81 
Market Cap ($ Bil)0.1 
First Trading Date06/22/1988 
Distance from 52W High-51.6% 
   50 Days200 Days
DMA Price$2.75$4.33
DMA Trenddowndown
Distance from DMA2.4%-35.0%
 3M1YR
Volatility91.2%68.1%
Downside Capture352.71121.93
Upside Capture23.5338.18
Correlation (SPY)29.2%21.9%
AVD Betas & Captures as of 4/30/2026

 1M2M3M6M1Y3Y
Beta0.311.501.211.071.030.84
Up Beta-0.250.800.670.521.561.07
Down Beta16.654.334.401.951.730.95
Up Capture101%-21%-32%36%15%3%
Bmk +ve Days15223166141428
Stock +ve Days10182858124365
Down Capture-147%257%175%147%95%102%
Bmk -ve Days4183056108321
Stock -ve Days9223259114355

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with AVD
AVD-33.3%68.3%-0.32-
Sector ETF (XLB)19.4%16.8%0.8833.9%
Equity (SPY)29.5%12.0%1.8622.0%
Gold (GLD)35.5%26.8%1.1112.2%
Commodities (DBC)42.9%18.7%1.77-13.0%
Real Estate (VNQ)15.2%13.1%0.8228.6%
Bitcoin (BTCUSD)-31.3%41.8%-0.788.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with AVD
AVD-31.3%53.9%-0.48-
Sector ETF (XLB)4.6%18.9%0.1434.6%
Equity (SPY)14.0%17.0%0.6425.2%
Gold (GLD)18.8%18.0%0.8510.0%
Commodities (DBC)10.4%19.4%0.428.0%
Real Estate (VNQ)3.8%18.8%0.1025.8%
Bitcoin (BTCUSD)11.6%55.3%0.4111.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return		Annualized
Volatility		Sharpe
Ratio		Correlation
with AVD
AVD-13.9%48.3%-0.12-
Sector ETF (XLB)10.3%20.6%0.4546.0%
Equity (SPY)15.7%17.9%0.7538.1%
Gold (GLD)13.0%16.0%0.677.0%
Commodities (DBC)7.8%17.9%0.3514.9%
Real Estate (VNQ)5.5%20.7%0.2333.9%
Bitcoin (BTCUSD)66.7%66.9%1.0611.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4302026
Short Interest: Shares Quantity1.0 Mil
Short Interest: % Change Since 4152026-5.0%
Average Daily Volume0.2 Mil
Days-to-Cover Short Interest4.5 days
Basic Shares Quantity28.6 Mil
Short % of Basic Shares3.5%

Returns Analyses

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
3/18/2026-13.6%-27.8%-12.6%
11/12/20253.3%-2.9%-11.3%
6/6/20251.6%-7.0%-13.8%
3/14/2025-5.7%1.1%-20.0%
11/12/20249.2%7.8%-10.5%
8/9/20249.4%11.3%18.2%
3/18/20244.7%8.0%-3.4%
11/9/2023-7.5%-5.1%3.5%
...
SUMMARY STATS   
# Positive986
# Negative111214
Median Positive1.6%6.6%12.1%
Median Negative-2.7%-5.2%-9.5%
Max Positive9.4%11.3%24.7%
Max Negative-16.4%-27.8%-24.5%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/06/202610-Q
12/31/202503/16/202610-K
09/30/202511/10/202510-Q
06/30/202507/31/202510-Q
03/31/202506/06/202510-Q
12/31/202405/29/202510-K
09/30/202411/12/202410-Q
06/30/202408/09/202410-Q
03/31/202405/09/202410-Q
12/31/202303/28/202410-K
09/30/202311/09/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202203/16/202310-K
09/30/202211/08/202210-Q
06/30/202208/08/202210-Q

Recent Forward Guidance [BETA]

Latest: Q4 2025 Earnings Reported 3/18/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Adjusted EBITDA44.00 Mil46.00 Mil48.00 Mil9.5% RaisedGuidance: 42.00 Mil for 2025

Prior: Q3 2025 Earnings Reported 11/12/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Adjusted EBITDA40.00 Mil42.00 Mil44.00 Mil0 AffirmedGuidance: 42.00 Mil for 2025

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value		Value of
Held Shares		Form
1Gottschalk, Patrick E DirectBuy51920262.7025,00067,500517,604Form
2Gottschalk, Patrick E DirectBuy51420262.9520,00059,000491,780Form
3Gottschalk, Patrick E DirectBuy51420262.9220,00058,400428,379Form
4Eilers, PeterSee RemarksDirectSell90520255.356,00032,100172,147Form
5Kaye, DouglasCHIEF EXECUTIVE OFFICERDirectBuy61220254.672,0009,3401,356,453Form

External Quote Links


Prefer one of these to Trefis? Tell us why.